Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.

Indian herbalists make extravagant claims for ashwagandha. But recent research shows that it offers significant sexual ...

Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Tralokinumab is effective in severe atopic dermatitis for up to 18 months, with patients who are naïve to some medications having faster benefits.

The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.

It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...